227 related articles for article (PubMed ID: 28064544)
1. Recent advances of pyrrolopyridines derivatives: a patent and literature review.
El-Gamal MI; Anbar HS
Expert Opin Ther Pat; 2017 May; 27(5):591-606. PubMed ID: 28064544
[TBL] [Abstract][Full Text] [Related]
2. 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).
Leoni A; Locatelli A; Morigi R; Rambaldi M
Expert Opin Ther Pat; 2016; 26(2):149-73. PubMed ID: 26561198
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
4. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
[TBL] [Abstract][Full Text] [Related]
6. 7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors.
Irie T; Sawa M
Chem Pharm Bull (Tokyo); 2018; 66(1):29-36. PubMed ID: 29311509
[TBL] [Abstract][Full Text] [Related]
7. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
Tandon VK; Kumar S
Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
[TBL] [Abstract][Full Text] [Related]
8. 7-Azaindole Analogues as Bioactive Agents and Recent Results.
Sharma N; Anurag
Mini Rev Med Chem; 2019; 19(9):727-736. PubMed ID: 30264679
[TBL] [Abstract][Full Text] [Related]
9. Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).
Leoni A; Locatelli A; Morigi R; Rambaldi M
Expert Opin Ther Pat; 2014 Feb; 24(2):201-16. PubMed ID: 24215328
[TBL] [Abstract][Full Text] [Related]
10. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor inhibitors: a patent review (2010 - present).
Li SN; Li HQ
Expert Opin Ther Pat; 2014 Mar; 24(3):309-21. PubMed ID: 24387079
[TBL] [Abstract][Full Text] [Related]
12. c-MET kinase inhibitors: a patent review (2011 - 2013).
Zhu K; Kong X; Zhao D; Liang Z; Luo C
Expert Opin Ther Pat; 2014 Feb; 24(2):217-30. PubMed ID: 24266843
[TBL] [Abstract][Full Text] [Related]
13. Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review.
Rathi AK; Syed R; Singh V; Shin HS; Patel RV
Recent Pat Anticancer Drug Discov; 2017; 12(1):55-72. PubMed ID: 27697069
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2.
Labadie S; Dragovich PS; Barrett K; Blair WS; Bergeron P; Chang C; Deshmukh G; Eigenbrot C; Ghilardi N; Gibbons P; Hurley CA; Johnson A; Kenny JR; Kohli PB; Kulagowski JJ; Liimatta M; Lupardus PJ; Mendonca R; Murray JM; Pulk R; Shia S; Steffek M; Ubhayakar S; Ultsch M; van Abbema A; Ward S; Zak M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7627-33. PubMed ID: 23107482
[TBL] [Abstract][Full Text] [Related]
15. Indazole derivatives and their therapeutic applications: a patent review (2013-2017).
Denya I; Malan SF; Joubert J
Expert Opin Ther Pat; 2018 Jun; 28(6):441-453. PubMed ID: 29718740
[TBL] [Abstract][Full Text] [Related]
16. TBK1 inhibitors: a review of patent literature (2011 - 2014).
Yu T; Yang Y; Yin DQ; Hong S; Son YJ; Kim JH; Cho JY
Expert Opin Ther Pat; 2015; 25(12):1385-96. PubMed ID: 26293650
[TBL] [Abstract][Full Text] [Related]
17. A FGFR1 inhibitor patent review: progress since 2010.
Yu T; Yang Y; Liu Y; Zhang Y; Xu H; Li M; Ponnusamy M; Wang K; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Apr; 27(4):439-454. PubMed ID: 27976968
[TBL] [Abstract][Full Text] [Related]
18. Indolinones as promising scaffold as kinase inhibitors: a review.
Prakash CR; Raja S
Mini Rev Med Chem; 2012 Feb; 12(2):98-119. PubMed ID: 22372601
[TBL] [Abstract][Full Text] [Related]
19. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature.
Giordanetto F; Karis D
Expert Opin Ther Pat; 2012 Dec; 22(12):1467-77. PubMed ID: 23136886
[TBL] [Abstract][Full Text] [Related]
20. Indirubin derivatives: a patent review (2010 - present).
Gaboriaud-Kolar N; Vougogiannopoulou K; Skaltsounis AL
Expert Opin Ther Pat; 2015 May; 25(5):583-93. PubMed ID: 25887337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]